CoChat

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

Open access
on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative, Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., Briggs, A., Hothersall, E. J., Morris, A. D., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Sattar, N. A., Wild, S. H., McKeigue, P., Colhoun, H. M. · 2013 · Diabetologia

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS programme collected between 2005 and 2011 for people aged ≥12 years with type 1 or type 2 diabetes in Scotland. We used hidden Markov models to calculate the probabilities of transitions to referable diabetic retinopathy (referable background or proliferative retinopathy) or referable maculopathy. RESULTS: The study included 155,114 individuals with no referable diabetic retinopathy or maculopathy at their first DRS examination and with one or more further DRS examinations. There were 11,275 incident cases of referable diabetic eye disease (9,204 referable maculopathy, 2,071 referable background or proliferative retinopathy). The observed transitions to referable background or proliferative retinopathy were lower for people with no visible retinopathy vs mild background retinopathy at their prior examination (respectively, 1.2% vs 8.1% for type 1 diabetes and 0.6% vs 5.1% for type 2 diabetes). The lowest probability for transitioning to referable background or proliferative retinopathy was among people with two consecutive screens showing no visible retinopathy, where the probability was <0.3% for type 1 and <0.2% for type 2 diabetes at 2 years. CONCLUSIONS/INTERPRETATION: Transition rates to referable diabetic eye disease were lowest among people with type 2 diabetes and two consecutive screens showing no visible retinopathy. If such people had been offered two yearly screening the DRS service would have needed to screen 40% fewer people in 2009.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-013-2928-7

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Transition probabilities to referable background retinopathy (R3) or proliferative retinopathy (R4) from no visible retinopathy by sex and diabetes duration in type 1 diabetes for 1 or 2 yearly screening intervals when last screening showed no visible retinopathy (a) and when last screening showed no visible retinopathy but previous screening showed mild background retinopathy (b). Blue filled squares, men with 1 year screening interval; blue open squares, men with 2 year screening interval; red filled circles, women with 1 year screening interval; red open circles, women with 2 year screening interval
Fig. 1 Transition probabilities to referable background retinopathy (R3) or proliferative retinopathy (R4) from no visible retinopathy by sex and diabetes duration in type 1 diabetes for 1 or 2 yearly screening intervals when last screening showed no visible retinopathy (a) and when last screening showed no visible retinopathy but previous screening showed mild background retinopathy (b). Blue filled squares, men with 1 year screening interval; blue open squares, men with 2 year screening interval; red filled circles, women with 1 year screening interval; red open circles, women with 2 year screening intervalCC BY-NC · PubMed Central
Fig. 2 Transition probabilities to referable background retinopathy (R3) or proliferative retinopathy (R4) from no visible retinopathy by sex and diabetes duration in type 2 diabetes for 1 or 2 yearly screening intervals when last screening showed no visible retinopathy (a) and when last screening showed no visible retinopathy but previous screening showed mild background retinopathy (b). Blue filled squares, men with 1 year screening interval; blue open squares, men with 2 year screening interval; red filled circles, women with 1 year screening interval; red open circles, women with 2 year screening interval
Fig. 2 Transition probabilities to referable background retinopathy (R3) or proliferative retinopathy (R4) from no visible retinopathy by sex and diabetes duration in type 2 diabetes for 1 or 2 yearly screening intervals when last screening showed no visible retinopathy (a) and when last screening showed no visible retinopathy but previous screening showed mild background retinopathy (b). Blue filled squares, men with 1 year screening interval; blue open squares, men with 2 year screening interval; red filled circles, women with 1 year screening interval; red open circles, women with 2 year screening intervalCC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 1

  1. Facey K, Cummins E, Macpherson K, Morris K, Reay L, Slattery J (2002) Organisation of services for diabetic retinopathy screening. Health Technology Assessment Report 1. Health Technology Board for Scotland, Glasgow

Cited by

See all 89

Metadata

Authors
on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative, Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., Briggs, A., Hothersall, E. J., Morris, A. D., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Sattar, N. A., Wild, S. H., McKeigue, P., & Colhoun, H. M.
Affiliations
  • University of Dundee (GB)
  • NHS Lanarkshire (GB)
  • Aberdeen Royal Infirmary (GB)
  • Ninewells Hospital (GB)
  • NHS Grampian (GB)
  • NHS Highland (GB)
  • Forth Valley Royal Hospital (GB)
  • University of Glasgow (GB)
  • Western General Hospital (GB)
  • University of Edinburgh (GB)
Corresponding author
Looker, H. C.
Venue
Diabetologia
Published
2013-05-21
Volume
56
Issue
8
Pages
1716-1725
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2082965216
Cited by
80
References
21
Citations by year
2026: 2 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 2 · 2018: 4 · 2017: 9 · 2016: 7 · 2015: 12 · 2014: 6 · 2013: 2
FWCI
8.86
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
Funders
  • Wellcome Trust (/WT086113)
  • NHS Health Scotland
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetic retinopathy, screening frequency, type 1 diabetes, type 2 diabetes, referable diabetic retinopathy, proliferative diabetic retinopathy, background retinopathy, hidden Markov models, transition probabilities, screening efficiency
MeSH terms
Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Humans, Male, Mass Screening, Middle Aged, Retrospective Studies, Scotland, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. https://app.cochat.ai/papers/10.1007/s00125-013-2928-7
The paper
on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative, Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., Briggs, A., Hothersall, E. J., Morris, A. D., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Sattar, N. A., Wild, S. H., McKeigue, P., & Colhoun, H. M. (2013). Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia. https://doi.org/10.1007/s00125-013-2928-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.